Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Phase II Clinical Trial of Moderately Hypofractionated Radiotherapy (70 Gy in 28 Fractions vs 60 Gy in 20 Fractions) Using Helical Tomotherapy.

NCT03827616 is registered in ClinicalTrials.gov with Tatarstan Cancer Center as lead sponsor.

NCT NCT03827616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03827616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Phase II Clinical Trial of Moderately Hypofractionated Radiotherapy (70 Gy in 28 Fractions vs 60 Gy in 20 Fractions) Using Helical Tomotherapy.
Lead sponsor
Tatarstan Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 25, 2019
Completion date
February 1, 2030
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital neoplasms, prostatic neoplasms